PLx Pharma Inc. Human Resources Contracts & Agreements
34 Contracts & Agreements
- Bonus & Incentive Agreements (5 contracts)
- Consulting Agreements (1)
- Employment Agreements (23)
- Retention Agreements (2)
- Separation Agreements (1)
- Severance Agreements (2)
- Severance and Settlement Agreement and Release of All Claims, dated February 9, 2023, by and between the Company and Michael Valentino (Filed With SEC on February 13, 2023)
- PLx Pharma Inc. 2023 Key Executive Retention Plan (Filed With SEC on February 13, 2023)
- Form of Award Notice under PLx Pharma Inc. 2023 Key Executive Retention Plan (Filed With SEC on February 13, 2023)
- Second Amendment to Employment Agreement, dated August 3, 2021, by and between the Company and Rita OConnor (Filed With SEC on August 6, 2021)
- Amendment to Employment Agreement with Natasha Giordano, dated March 7, 2019 (Filed With SEC on March 8, 2019)
- Amendment to Employment Agreement with Rita OConnor, dated March 16, 2018 (Filed With SEC on March 8, 2019)
- Amendment to Employment Agreement with Rita OConnor, dated March 7, 2019 (Filed With SEC on March 8, 2019)
- AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2019)
- Amendment to Employment Agreement with Michael Valentino, dated March 7, 2019 (Filed With SEC on March 8, 2019)
- 2018 Incentive Plan (Filed With SEC on November 9, 2018)
- Employment Agreement, dated as of August 29, 2018, by and between the Company and Efthymios Deliargyris (Filed With SEC on August 31, 2018)
- Amendment to Amended and Restated Employment Agreement of Gary Mossman (Filed With SEC on September 19, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 2, 2017)
- SEPARATION AND SETTLEMENT AGREEMENT AND RELEASE OF ALL CLAIMS (Filed With SEC on May 2, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 20, 2017)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on April 20, 2017)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on April 20, 2017)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on April 20, 2017)
- SEVERANCE AND RELEASE AGREEMENT (Filed With SEC on December 14, 2016)
- PLXPHARMA INC. 2015OMNIBUS INCENTIVE PLAN ARTICLE 1 PURPOSE (Filed With SEC on October 5, 2015)
- AWARD AGREEMENT PLx Pharma Inc. 2015Omnibus Incentive Plan IncentiveStock Option (Filed With SEC on October 5, 2015)
- AWARD AGREEMENT PLxPharma Inc. 2015 Omnibus Incentive Plan Non-QualifiedStock Option (Filed With SEC on October 5, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 5, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 5, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 5, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 5, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 5, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 5, 2015)
- CONSULTING AGREEMENT (Filed With SEC on June 9, 2014)
- DIPEXIUM PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on February 6, 2014)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on February 6, 2014)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on February 6, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 6, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 6, 2014)
